Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

NCT01602029 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

303

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Psychosis Not Otherwise Specified
Schizophreniform Disorder

Interventions

DRUG: Ondansetron
DRUG: Simvastatin
DRUG: Placebo
DRUG: Odansetron plus simvastatin

Sponsor

Pakistan Institute of Living and Learning

Collaborators

[object Object]
[object Object]
[object Object]